Back then everyone wanted to own large cap growth funds. You could take your pick of hundreds in the category. A few were really good, a few really bad, and most were average. I saw frustrated investors simply give up trying to choose and throw their money at whatever was convenient. Usually it didn't work out so well.
The good news is that the ETF structure should allow us to avoid some of the ill effects of the mutual fund boom.
As Americans, we're all about freedom. We choose our cars from a showroom, our food from a menu, and our flowers from a nursery. We don't like being forced to take whatever happens to be available.
No one likes having too many choices.
It's possible, though, to have too many choices. At some point we get overwhelmed and paralyzed. Then we do nothing — even when we should. This is as true with investing as with everything else and can lead to ...
Now we're approaching the same crossroads in the ETF era. According to my data, at the end of June there were 914 exchange-traded funds and 95 exchange-traded notes available to U.S. investors. That's well over 1,000 choices with more coming to market every week.
Want large cap growth? You have to pick from 13 ETFs now on the market, not counting leveraged and inverse ones. Looking to bet on a sector — technology, for example? More than 30 technology-related ETFs are now available!
Do we need so many ETFs? Yes and no.
Many are duplicative or have a lot of overlap in their portfolio holdings. The big sponsors all want to stay competitive by covering every niche.
To some degree, this is a good thing. Competition leads to better products, more efficiency, and lower costs for everyone. I always appreciate having choices when I make investment decisions.
On the other hand, as the market is sliced into smaller and smaller pieces, investor interest in some segments is simply not enough to support a half-dozen different ETFs.
So what happens is that the biggest firms — the ones with well-known brand names and big marketing budgets — tend to dominate the menu. That's too bad; there are some smaller upstart companies that deserve a break. Yet it's a fact of life.
However, there is a problem when investing in the smaller ETFs ...
The ETF Liquidity Trap
As people who are used to investing in mutual funds switch to ETFs, many run into something they never had to worry about before: Liquidity.
No-load mutual funds can typically be bought and sold at the daily net asset value, or NAV. ETFs are bought and sold on an exchange and their price changes throughout the day.
There are really two prices: The "ask" price, which is what you will pay to buy the shares with a market order; and the "bid" price, which is what you will receive for selling your shares with a market order. The difference between these two prices is what is known as the "spread."
Here's the problem:
The largest 100 or so ETFs typically trade with just a one or two-cent spread. However, small and thinly traded ETFs might have spreads of 10 cents, 20 cents, or more. If, for instance, the share price is around $20, you could lose nearly one percent just buying and selling shares even while the price remains steady.
What this means is that you can't just look at an ETF's past performance when deciding whether to jump in. You also need to consider its size, trading volume, and institutional involvement.
Here is a quick example:
Say you want to invest in the real estate sector. Someone tells you that PowerShares Active U.S. Real Estate Fund (PSR) has done very well, up 52.7 percent in the last twelve months. You do a little checking and find out that PSR edged out iShares Dow Jones U.S. Real Estate (IYR), which gained 51.2 percent in the same period.
Dig a little deeper. It turns out that IYR has assets of more than $2,440 million ($2.4 billion), while PSR only has about $4 million.
Look at the trading activity, too. Average daily dollar volume is more than $900 million for IYR. For PSR, the typical day only generates about $0.2 million in trading activity.
Which do you choose? I know what I would do. Performance in the two ETFs is very similar, but IYR is far bigger and way more actively traded. There are no guarantees, of course. Nevertheless, IYR gives me more assurance I can buy or sell efficiently and at a fair price.
As you can see, it's not hard to lose an extra percent or two on each entry and exit in an illiquid ETF. This can quickly eliminate any performance advantage you think you're getting from a small, unknown fund.
The example above is not just cherry-picking. I could name many other ETFs that look like they have good results but are even smaller and less popular.
I always consider these factors when I'm looking for ETFs. And I try to avoid the small, thinly-traded ones. Should you do likewise?
In my opinion, most people are better off sticking to the beaten path. Once you decide to move into a particular sector or market category, do a little homework and find out which ETFs have the best liquidity in the group.
However, if you have access to reliable, real-time market data and don't mind "working" your orders to get the best prices, you can probably make good use of some smaller ETFs. This takes some time and specialized knowledge.
Either way, ETFs are one of the most useful investment tools to come along in decades. Learn about them, know them, and consider using them!
P.S. My just-released ETF Field Guide includes everything you need to get on the right track for profitable ETF investing. And the companion proprietary ETF Shopper's Handbook gives you easy-to-understand data so you can find the cream of the cream among more than 1,000 ETFs and ETNs. You don't want to be without this one-of-a kind resource if you invest in ETFs. Click here to learn more.
This investment news is brought to you by Money and Markets. Money and Markets is a free daily investment newsletter from Martin D. Weiss and Weiss Research analysts offering the latest investing news and financial insights for the stock market, including tips and advice on investing in gold, energy and oil. Dr. Weiss is a leader in the fields of investing, interest rates, financial safety and economic forecasting. To view archives or subscribe, visit http://www.moneyandmarkets.com.
|< Prev||Next >|
Current Headlines - Finance
Indonesia military cargo plane crashes in Medan, dozens dead
Crunch time for Greece as IMF debt looms and bailout ends
ATHENS, Greece (AP) — It's crunch time for Greece, with the European part of its international bailout expiring Tuesday and with it any possible access to the remaining rescue loans that it needs to pay its debts.
S&P says Japan's Sharp in 'selective default'
Troubled Japanese electronics maker Sharp is in "selective default" ratings agency S&P said Tuesday, the latest blow to the one-time giant as it struggles to repair a tattered balance sheet. The move comes after Sharp announced that it was issuing preferred securities to its main lenders, instead of repaying loans that were due. "Once a debt-for-equity swap that we define as a default is completed, we review the company's post-swap credit profile and raise the issuer credit rating from 'SD' as swiftly as possible, in accordance with our criteria.
MIDEAST STOCKS-Saudi slides on weak petrochemicals
DUBAI, June 30 (Reuters) - Saudi Arabia's stock market continued falling in early trade on Tuesday, led by petrochemicals, which sagged as the Greek debt crisis weighed on oil prices. The main Saudi stock index slid 1.3 percent, heading for its third straight daily fall, as the biggest petrochemical producer, Saudi Basic Industries, dropped 1.4 percent. Miner Ma'aden, another blue chip which has been hit hard in the market's retreat, fell 1.5 percent. But Saudi Ground Services, which listed last Thursday after an initial public offer at a price of 50 riyals per share, climbed 7.5 percent to ...
China fund association seeks to rally confidence as stocks tumble
China's fund association on Tuesday sought to rally confidence as the country's stock markets tumbled, by saying the falling prices presented valuable buying opportunities if hedge fund managers made rational investment decisions. "Confidence is more important than gold," Asset Management Association of China (AMAC) said in a statement on its website. China's stock market has seen wild swings over the past two weeks, with panic selling by investors knocking the Shanghai Composite Index down over one fifth from its June 12 high.
IndiGo to file prospectus for $400 million listing on Tuesday - sources
India's biggest airline, IndiGo, is likely to file the prospectus for a stock market listing that will raise around $400 million later on Tuesday, two banking sources with knowledge of the matter said. The initial public offering will include about $200 million of fresh equity infusion, the sources said, declining to be named because they were not authorised to speak to the media. IndiGo, owned by hospitality and travel company InterGlobe Enterprises, is India's largest airline by market share.
Global equity market deals top $500 billion but banker fees fall
By Freya Berry and Elzio Barreto LONDON/HONG KONG (Reuters) - Money raised in global equity capital markets rose in the first half of the year to top $500 billion, but bankers' fees fell as secondary share sales supplanted lucrative stock market listings as the dominant deals. The rise in secondary sales was partly down to private equity funds taking the opportunity to sell down stakes in companies that floated last year, following the expiration of "lock-up" periods when shares cannot be sold, analysts said. Initial public offerings (IPOs) had reigned supreme in the first half of last year, but they dropped by 18 percent to $96.8 billion in the same period of 2015, Thomson Reuters data showed on Tuesday.
Shot during capture, New York inmate in serious condition
Sweat, 35, was being treated at Albany Medical Center following his capture on Sunday near the Canadian border. Fellow escapee Richard Matt was shot and killed on Friday. The convicted murderers escaped from the Clinton Correctional Facility in Dannemora, New York, where they were discovered missing on June 6.
Divided U.S. Supreme Court upholds Oklahoma lethal injection process
By Lawrence Hurley WASHINGTON (Reuters) - The Supreme Court on Monday found that a lethal injection drug used by Oklahoma does not violate the U.S. Constitution's ban on cruel and unusual punishment, a ruling that provoked a caustic debate among the justices about the death penalty in America. The 5-4 ruling, with the court's five conservatives in the majority, prompted liberal Justices Stephen Breyer and Ruth Bader Ginsburg to say for the first time they believe capital punishment as currently practiced may be unconstitutional. The decision was a defeat for death penalty foes and for the three death row inmates who challenged the use of a sedative called midazolam as part of Oklahoma's lethal injection process, saying it cannot achieve the level of unconsciousness required for surgery, making it unsuitable for executions.
Why Chris Christie has to run for president to stay afloat in New Jersey